Hwang Takes Helm of Metaphore Biotechnologies

Portfolio - People | Nov 20, 2024 | Flagship Pioneering Inc

Flagship Pioneering, a bioplatform innovation company, has announced the appointment of Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies, effective January 1, 2025. Hwang, who brings nearly three decades of experience from her tenure with Pfizer, where she served as Chief Commercial Officer, will lead Metaphore as it seeks to harness the power of its MIMIC platform to advance innovative therapeutics. Her appointment underscores Metaphore's ambition to disrupt treatment landscapes across various diseases by optimizing key molecular features for specific biological functions. This move also marks a significant leadership transition for Metaphore as it prepares to build on its collaboration with companies like Novo Nordisk. Throughout her career, Hwang has been recognized for her impactful leadership and contributions to the global healthcare sector.

Sectors

  • Biotechnology
  • Pharmaceutical

Geography

  • United States – Both Flagship Pioneering and Metaphore Biotechnologies are based in the United States, with the announcement taking place in Cambridge, Massachusetts.

Industry

  • Biotechnology – The article focuses on Metaphore Biotechnologies, a company in the biotechnology sector, which designs novel therapeutics.
  • Pharmaceutical – The article relates to Angela Hwang's previous role at Pfizer, a major pharmaceutical company, highlighting her extensive experience in drug development and commercialization.

Financials

  • $60 billion – The aggregate value created by Flagship Pioneering's ventures.
  • $14 billion – Assets under management by Flagship Pioneering as of the latest capital raise in July 2024.

Participants

NameRoleTypeDescription
Flagship PioneeringPrivate Equity FirmCompanyA bioplatform innovation company that invents and builds biotechnology companies.
Metaphore BiotechnologiesTarget CompanyCompanyA Flagship-founded biotechnology company focused on designing therapeutics using machine learning and molecular mimicry.
Angela HwangChief Executive OfficerPersonRecently appointed CEO of Metaphore Biotechnologies, with an extensive background at Pfizer.
PfizerPrevious EmployerCompanyA global pharmaceutical corporation where Angela Hwang served as Chief Commercial Officer.
Novo NordiskResearch PartnerCompanyCollaborated with Metaphore Biotechnologies on developing therapeutics in the GLP1-R biology space.
Noubar AfeyanFounder and CEOPersonFounder and CEO of Flagship Pioneering.
Lovisa AfzeliusGeneral Partner and Co-FounderPersonGeneral Partner at Flagship Pioneering and Co-Founder of Metaphore Biotechnologies.